Investor Relations Immune Design

The Investor Relations website contains information about Immune Design business for stockholders, potential investors, and financial analysts.

OVERVIEW

This web site ir.immunedesign.com presently has an average traffic ranking of zero (the smaller the better). We have evaluated twenty pages inside the web page ir.immunedesign.com and found fifty websites linking to ir.immunedesign.com. There are two public communication accounts possessed by this website.
Pages Analyzed
20
Links to this site
50
Social Links
2

IR.IMMUNEDESIGN.COM RANKINGS

This web site ir.immunedesign.com is seeing diverging quantities of traffic through the year.
Traffic for ir.immunedesign.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.immunedesign.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.immunedesign.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO BUSINESS

WHAT DOES IR.IMMUNEDESIGN.COM LOOK LIKE?

Desktop Screenshot of ir.immunedesign.com Mobile Screenshot of ir.immunedesign.com Tablet Screenshot of ir.immunedesign.com

IR.IMMUNEDESIGN.COM HOST

Our web crawlers caught that a single page on ir.immunedesign.com took three hundred and fifty-three milliseconds to download. I could not detect a SSL certificate, so therefore our web crawlers consider this site not secure.
Load time
0.353 seconds
SSL
NOT SECURE
Internet Address
206.200.251.19

SERVER OPERATING SYSTEM AND ENCODING

I found that ir.immunedesign.com is utilizing the Microsoft-IIS/6.0 operating system.

TITLE

Investor Relations Immune Design

DESCRIPTION

The Investor Relations website contains information about Immune Design business for stockholders, potential investors, and financial analysts.

CONTENT

This web site states the following, "Harnessing the Immune System to Fight Disease." Our analyzers saw that the web page also said " Immune Design is a clinical stage immunotherapy company employing next-generation." The Website also said " Immune Design Reports Second Quarter 2015 Financial Results. Immune Design Announces Phase 2 Cancer Immunotherapy Trial Collaboration. View all news releases . Aug 12, 2015 at 130 PM PT. Immune Design Second Quarter 2015 Financial Results. Jun 3, 2015 at 200 PM ET."

SIMILAR WEB PAGES

immersive art network This WordPress.com site is the bees knees

Create a free website or blog at WordPress. Create a free website or blog at WordPress. Get every new post delivered to your Inbox. Build a website with WordPress.

The ATOM Log In

Larr; Back to The ATOM.

Dr. Dipnarine Maharaj M.D. FACP

Dr Dipnarine Maharaj MD, FACP, Adult Stem Cell Transplant Physician. News Articles on Dipnarine Maharaj. Thursday, October 3, 2013. Dr Dipnarine Maharaj Continues Community Outreach Education Program with Lecture to Scleroderma Foundatoin Tonight. Medical Director - South Florida Bone Marrow Stem Cell Transplant Institute.

Immune Milk

These statements have not been evaluated by the Food and Drug Administration. The products mentioned here are not intended to diagnose, treat, cure or prevent any disease.